Synonyms: VX993
VX-993 is an approved drug
Compound class:
Synthetic organic
Comment: VX-993 is an orally bioavailable NaV1.8 ion channel inhibitor [1]. NaV1.8 is a validated target for the development of non-opioid analgesics.
|
|
No information available. |
Summary of Clinical Use ![]() |
VX-993 has progressed to clinical evaluations, to determine safety and efficacy as a treatment for pain disorders. |
Clinical Trials | |||||
Clinical Trial ID | Title | Type | Source | Comment | References |
NCT06619847 | A Study Evaluating Efficacy and Safety of VX-993 for Acute Pain After a Bunionectomy | Phase 2 Interventional | Vertex Pharmaceuticals Incorporated | ||
NCT06619860 | Evaluation of Efficacy and Safety of VX-993 for Pain Associated With Diabetic Peripheral Neuropathy | Phase 2 Interventional | Vertex Pharmaceuticals Incorporated |